Skip to main content
Top
Published in: BMC Primary Care 1/2014

Open Access 01-12-2014 | Research article

Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records

Authors: Anita WeyWey Lim, David Mesher, Peter Sasieni

Published in: BMC Primary Care | Issue 1/2014

Login to get access

Abstract

Background

Ovarian cancer is the most lethal gynaecological malignancy in the United Kingdom (UK). Studies have found that many women with ovarian cancer have symptoms for several months before diagnosis. Using a symptoms-based tool to diagnose ovarian cancer (OC) earlier is appealing, but may increase general practitioner (GP) workload because the symptoms are typically vague and non-specific. This study aimed to provide estimates of the GP workload associated with offering symptoms-based ovarian cancer screening.

Methods

A cross-sectional analysis of electronic records from four general practices in England, UK. We downloaded anonymous data on women aged 45–74 who consulted over one week to estimate the proportion who would be offered ‘screening’ according to the UK National Institute for Health and Care Excellence (NICE) guidelines and a symptoms index (Index 2) over one year. We used previous consultations (censoring women with no prior symptom at the date of their last recorded consultation) to estimate the proportion of women presenting with a new (not recorded in previous 12 months) NICE symptom each year.

Results

Data were obtained from 19,558 women. The proportion presenting over one week varied between practices (5%-14%), however, the proportion with an OC symptom was similar (17% overall). Over one year, an estimated 51.8% (95% CI 44.0%-59.7%) would present with an OC symptom, 26.6% (95% CI 19.3%-35.1%) with a NICE symptom and 20.3% (95% CI 13.7%-28.5%) with an Index 2 symptom. Each year, an estimated 11.9% (95% CI 5.0%-18.3%) of women would present with a new NICE symptom.

Conclusion

One in two women aged 45–74 present to primary care at least once a year with an OC symptom, 11.9% with a new NICE symptom. This would be comparable to 2 to 8 yearly screening (depending on what symptoms triggered testing).
Literature
2.
go back to reference Chan YM, Ng TY, Lee PW, Ngan HY, Wong LC: Symptoms, coping strategies, and timing of presentations in patients with newly diagnosed ovarian cancer. Gynecol Oncol. 2003, 90 (3): 651-656. 10.1016/S0090-8258(03)00394-9.CrossRefPubMed Chan YM, Ng TY, Lee PW, Ngan HY, Wong LC: Symptoms, coping strategies, and timing of presentations in patients with newly diagnosed ovarian cancer. Gynecol Oncol. 2003, 90 (3): 651-656. 10.1016/S0090-8258(03)00394-9.CrossRefPubMed
3.
go back to reference Eltabbakh GH, Yadav PR, Morgan A: Clinical picture of women with early stage ovarian cancer. Gynecol Oncol. 1999, 75 (3): 476-479. 10.1006/gyno.1999.5621.CrossRefPubMed Eltabbakh GH, Yadav PR, Morgan A: Clinical picture of women with early stage ovarian cancer. Gynecol Oncol. 1999, 75 (3): 476-479. 10.1006/gyno.1999.5621.CrossRefPubMed
4.
go back to reference Goff BA, Mandel L, Muntz HG, Melancon CH: Ovarian carcinoma diagnosis. Cancer. 2000, 89 (10): 2068-2075. 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z.CrossRefPubMed Goff BA, Mandel L, Muntz HG, Melancon CH: Ovarian carcinoma diagnosis. Cancer. 2000, 89 (10): 2068-2075. 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z.CrossRefPubMed
5.
go back to reference Goff BA, Mandel LS, Melancon CH, Muntz HG: Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004, 291 (22): 2705-2712. 10.1001/jama.291.22.2705.CrossRefPubMed Goff BA, Mandel LS, Melancon CH, Muntz HG: Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004, 291 (22): 2705-2712. 10.1001/jama.291.22.2705.CrossRefPubMed
6.
go back to reference Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S: Symptoms of ovarian cancer. Obstet Gynecol. 2001, 98 (2): 212-217. 10.1016/S0029-7844(01)01457-0.PubMed Olson SH, Mignone L, Nakraseive C, Caputo TA, Barakat RR, Harlap S: Symptoms of ovarian cancer. Obstet Gynecol. 2001, 98 (2): 212-217. 10.1016/S0029-7844(01)01457-0.PubMed
7.
go back to reference Smith EM, Anderson B: The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer. 1985, 56 (11): 2727-2732. 10.1002/1097-0142(19851201)56:11<2727::AID-CNCR2820561138>3.0.CO;2-8.CrossRefPubMed Smith EM, Anderson B: The effects of symptoms and delay in seeking diagnosis on stage of disease at diagnosis among women with cancers of the ovary. Cancer. 1985, 56 (11): 2727-2732. 10.1002/1097-0142(19851201)56:11<2727::AID-CNCR2820561138>3.0.CO;2-8.CrossRefPubMed
8.
go back to reference Vine MF, Calingaert B, Berchuck A, Schildkraut JM: Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003, 90 (1): 75-82. 10.1016/S0090-8258(03)00175-6.CrossRefPubMed Vine MF, Calingaert B, Berchuck A, Schildkraut JM: Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003, 90 (1): 75-82. 10.1016/S0090-8258(03)00175-6.CrossRefPubMed
9.
go back to reference Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A: Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001, 83 (3): 466-471. 10.1006/gyno.2001.6411.CrossRefPubMed Vine MF, Ness RB, Calingaert B, Schildkraut JM, Berchuck A: Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001, 83 (3): 466-471. 10.1006/gyno.2001.6411.CrossRefPubMed
10.
go back to reference Yawn BP, Barrette BA, Wollan PC: Ovarian cancer: the neglected diagnosis. Mayo Clin Proc. 2004, 79 (10): 1277-1282. 10.4065/79.10.1277.CrossRefPubMed Yawn BP, Barrette BA, Wollan PC: Ovarian cancer: the neglected diagnosis. Mayo Clin Proc. 2004, 79 (10): 1277-1282. 10.4065/79.10.1277.CrossRefPubMed
11.
go back to reference Friedman GD, Skilling JS, Udaltsova NV, Smith LH: Early symptoms of ovarian cancer: a case–control study without recall bias. Fam Pract. 2005, 22 (5): 548-553. 10.1093/fampra/cmi044.CrossRefPubMed Friedman GD, Skilling JS, Udaltsova NV, Smith LH: Early symptoms of ovarian cancer: a case–control study without recall bias. Fam Pract. 2005, 22 (5): 548-553. 10.1093/fampra/cmi044.CrossRefPubMed
12.
go back to reference Lim AWW, Mesher D, Gentry-Maharaj A, Balogun N, Jacobs I, Menon U, Sasieni P: Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes. J Natl Cancer Inst. 2012, 104 (2): 114-124. 10.1093/jnci/djr486.CrossRefPubMed Lim AWW, Mesher D, Gentry-Maharaj A, Balogun N, Jacobs I, Menon U, Sasieni P: Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes. J Natl Cancer Inst. 2012, 104 (2): 114-124. 10.1093/jnci/djr486.CrossRefPubMed
13.
go back to reference Smith LH, Morris CR, Yasmeen S, Parikh-Patel A, Cress RD, Romano PS: Ovarian cancer: Can we make the clinical diagnosis earlier?. Cancer. 2005, 104 (7): 1398-1407. 10.1002/cncr.21310.CrossRefPubMed Smith LH, Morris CR, Yasmeen S, Parikh-Patel A, Cress RD, Romano PS: Ovarian cancer: Can we make the clinical diagnosis earlier?. Cancer. 2005, 104 (7): 1398-1407. 10.1002/cncr.21310.CrossRefPubMed
14.
go back to reference National Institute for Health and Clinical Excellence: Ovarian cancer: the recognition and initial management of ovarian cancer. Clinical guidelines CG122. Edited by NICE, vol. CG122; 2011. Available from: [http://www.nice.org.uk/guidance/cg122] (accessed 29/07/2014)., National Institute for Health and Clinical Excellence: Ovarian cancer: the recognition and initial management of ovarian cancer. Clinical guidelines CG122. Edited by NICE, vol. CG122; 2011. Available from: [http://​www.​nice.​org.​uk/​guidance/​cg122] (accessed 29/07/2014).,
16.
go back to reference Royal College of General Practitioners: General Practice in the UK: A Basic Overview. RCGP Information Sheet No 4. 2005, vol. 4: ᅟ- Royal College of General Practitioners: General Practice in the UK: A Basic Overview. RCGP Information Sheet No 4. 2005, vol. 4: ᅟ-
17.
go back to reference Hamilton W, Peters TJ, Bankhead C, Sharp D: Risk of ovarian cancer in women with symptoms in primary care: population based case–control study. BMJ. 2009, 339: b2998-10.1136/bmj.b2998.CrossRefPubMedPubMedCentral Hamilton W, Peters TJ, Bankhead C, Sharp D: Risk of ovarian cancer in women with symptoms in primary care: population based case–control study. BMJ. 2009, 339: b2998-10.1136/bmj.b2998.CrossRefPubMedPubMedCentral
18.
go back to reference Grewal K, Hamilton W, Sharp D: Ovarian cancer prediction: development of a scoring system for primary care. BJOG. 2013, 120 (8): 1016-1019. 10.1111/1471-0528.12200.CrossRefPubMed Grewal K, Hamilton W, Sharp D: Ovarian cancer prediction: development of a scoring system for primary care. BJOG. 2013, 120 (8): 1016-1019. 10.1111/1471-0528.12200.CrossRefPubMed
19.
go back to reference Rufford BD, Jacobs I, Menon U: Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG. 2007, 114 (1): 59-64. 10.1111/j.1471-0528.2006.01153.x.CrossRefPubMed Rufford BD, Jacobs I, Menon U: Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG. 2007, 114 (1): 59-64. 10.1111/j.1471-0528.2006.01153.x.CrossRefPubMed
20.
go back to reference Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ: Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009, 101 (Suppl 2): S92-S101. 10.1038/sj.bjc.6605398.CrossRefPubMedPubMedCentral Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ: Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009, 101 (Suppl 2): S92-S101. 10.1038/sj.bjc.6605398.CrossRefPubMedPubMedCentral
21.
go back to reference Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B: Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol. 2012, 127 (1): 75-82. 10.1016/j.ygyno.2012.06.033.CrossRefPubMed Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B: Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol. 2012, 127 (1): 75-82. 10.1016/j.ygyno.2012.06.033.CrossRefPubMed
22.
go back to reference Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, et al: Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009, 10 (4): 327-340. 10.1016/S1470-2045(09)70026-9.CrossRefPubMed Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, et al: Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009, 10 (4): 327-340. 10.1016/S1470-2045(09)70026-9.CrossRefPubMed
23.
go back to reference Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR: Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007, 109 (2): 221-227. 10.1002/cncr.22371.CrossRefPubMed Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR: Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007, 109 (2): 221-227. 10.1002/cncr.22371.CrossRefPubMed
Metadata
Title
Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records
Authors
Anita WeyWey Lim
David Mesher
Peter Sasieni
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2014
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/s12875-014-0200-y

Other articles of this Issue 1/2014

BMC Primary Care 1/2014 Go to the issue